January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
August 20, 2025 - 04:13
Disney Strengthens Leadership Team Ahead of ESPN Streaming LaunchOn the eve of ESPN`s long-anticipated direct-to-consumer streaming launch, Disney has added two key lieutenants to senior executive Adam Smith`s team. This strategic move aims to bolster the...
August 19, 2025 - 04:50
Argentina's Science and Technology Budget Hits Record Low Since 2002Argentina`s budget allocation for science and technology has reached its lowest point in over two decades, raising concerns among researchers and academics about the future of innovation in the...
August 18, 2025 - 21:54
Ray-Ban Meta Smart Glasses Enhanced by Be My Eyes for Vision SupportIn an exciting development for wearable technology, Ray-Ban Meta smart glasses are now integrated with Be My Eyes, transforming them into a powerful assistive tool for individuals with visual...
August 18, 2025 - 11:17
Vatican's AI Guidelines Overlook Intersection of Evolution and TechnologyThe Vatican`s recent guidelines on artificial intelligence have sparked debate, particularly regarding their approach to the relationship between technological advancement and the principles of...